- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Onera Health wakes up to $12.7m
Imec.xpand has returned to back a series B round for sleep diagnostic developer Onera Health, spun out of Imec.
Jul 29, 2021Investors assist Artios in $153m series C
IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.
Jul 29, 2021Sema4 secures Nasdaq listing
SoftBank has contributed to a $350m private placement supporting the health screening provider's reverse takeover.
Jul 29, 2021Investors assist Artios in $153m series C
M Ventures, Novartis Venture Fund and Pfizer Ventures are among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.
Jul 29, 2021Sema4 secures Nasdaq listing
Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.
Jul 29, 2021Daily Deal Round Up: July 28, 2021
Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.
Jul 28, 2021India's rising economic power
Venture capital funding for Indian firms hit a six-year high of $12.1bn in the first six months of 2021
Jul 28, 2021RxCelerate explores corporate venturing
The newly formed RxCapital has made its first investment, in metabolic and cardiovascular disease drug developer Rivus Pharmaceuticals' $35m series A round.
Jul 28, 2021Choudhry leaves Cigna Ventures for startup
Craig Cimini will be the remaining managing director at health insurer Cigna's corporate venture capital subsidiary.
Jul 28, 2021Daily Deal Round Up: July 27, 2021
SAP.io took part in email software provider Sedna's $34m series B round while Byju's picked up BCC-backed learning app developer Toppr in a deal reportedly sized at about $150m.
Jul 27, 2021Sophia Genetics secures $234m in IPO
Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva
Jul 27, 2021Embark passes series B test with $75m
Dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.
Jul 27, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
